Increased levels of insulin‐like growth factor binding protein‐2 in sera and tumours from patients with colonic neoplasia with and without acromegaly
10.1046/j.1365-2265.2001.01221.x
Crossref journal-article
Wiley
Clinical Endocrinology (311)
Abstract

OBJECTIVE Patients with acromegaly are at increased risk of developing colorectal carcinoma and premalignant tubulovillous adenoma. The pathogenesis of these neoplasms could involve a stimulatory effect of serum growth factors on colonic epithelial cell proliferation. The aim of this study was to evaluate changes in (1) serum IGF‐I, IGF‐II, IGFBP‐3 and IGFBP‐2 and (2) changes in local expression of IGFBPs and p53 in colonic epithelium in patients with colonic neoplasia with and without acromegaly.DESIGN A cross‐sectional retrospective study was performed. Fasting serum samples were obtained at the time of colonoscopy for patients with acromegaly and at the time of surgery for patients with colonic neoplasia without acromegaly.MEASUREMENTS Serum IGF‐I, IGF‐II, IGFBP‐2 and IGFBP−3 were measured using specific immunoassays. Tissue expression of IGFBP‐2, IGFBP‐3 and p53 status were determined by immunohistochemistry.PATIENTS Group 1: 26 age‐ and sex‐matched control subjects (range 40–69 years); group 2: 18 patients with acromegaly without colonic neoplasia (range 39–68 years); group 3: 18 patients with acromegaly and colonic neoplasia (range 41–74 years, 11 = adenoma, seven = carcinoma); group 4: 19 patients with colonic neoplasia without endocrine disease (range 43–91 years, four = adenoma, 15 = carcinoma). Immunohistochemical staining of colonic biopsies was performed for IGFBP‐2, IGFBP‐3 and p53 in groups 3 and 4.RESULTS Mean serum IGF‐I and IGFBP‐3 levels were significantly elevated in group 2 (371 ± 131 µg/l and 6·5 ± 1·8 mg/l, respectively) and group 3 (379 ± 174 µg/l and 5·8 ± 1·6 mg/l, respectively), and significantly reduced in group 4 (103 ± 36 µg/l and 2·4 ± 1 mg/l) compared to controls (165 ± 40 µg/l and 4·7 ± 1 mg/l; P < 0·0001, P < 0·001, respectively). However, median serum IGFBP‐2 levels were significantly elevated in group 3 (P < 0·01) and group 4 (P < 0·0001). Immunostaining for IGFBP‐2 showed strong areas of immunoreactivity in the cytoplasm of malignant colonic epithelium compared to benign epithelium. IGFBP‐3 immunostaining showed strong areas of immunoreactivity in the cytoplasm and in the nucleus of malignant and benign colonic epithelium compared to the normal epithelium. Nuclear staining for p53 was observed in three patients from group 3 (two carcinoma, one adenoma) and four patients from group 4 (all carcinoma).CONCLUSION Our results describe changes in IGFBP‐2 expression in colonic neoplasia in patients with and without acromegaly, which suggest that this binding protein may regulate local bioavailability of IGF, which in turn could modulate colonic cell proliferation and/or differentiation.

Bibliography

Miraki‐Moud, F., Jenkins, P. J., Fairclough, P. D., Jordan, S., Bustin, S. A., Jones, A. M., Lowe, D. G., Monson, J. P., Grossman, A. B., Besser, G. M., & Camacho‐Hübner, C. (2001). Increased levels of insulin‐like growth factor binding protein‐2 in sera and tumours from patients with colonic neoplasia with and without acromegaly. Clinical Endocrinology, 54(4), 499–508. Portico.

Authors 11
  1. F. Miraki‐Moud (first)
  2. P. J. Jenkins (additional)
  3. P. D. Fairclough (additional)
  4. S. Jordan (additional)
  5. S. A. Bustin (additional)
  6. A. M. Jones (additional)
  7. D. G. Lowe (additional)
  8. J. P. Monson (additional)
  9. A. B. Grossman (additional)
  10. G. M. Besser (additional)
  11. C. Camacho‐Hübner (additional)
References 49 Referenced 23
  1. 10.1111/j.1365-2265.1995.tb01857.x
  2. 10.1210/jcem-70-5-1347
  3. {'key': 'e_1_2_6_4_1', 'first-page': '100', 'article-title': 'Clinical studies of IGFBP‐2 by radioimmunoassay', 'volume': '3', 'author': 'Blum W.F.', 'year': '1993', 'journal-title': 'Growth Regulation'} / Growth Regulation / Clinical studies of IGFBP‐2 by radioimmunoassay by Blum W.F. (1993)
  4. 10.1210/jcem-70-5-1292
  5. 10.1210/endo-128-2-805
  6. 10.1111/j.1365-2265.1990.tb03751.x
  7. 10.1038/377646a0
  8. {'key': 'e_1_2_6_9_1', 'first-page': '523', 'article-title': 'Increased epithelial cell proliferation in the colon of patients with acromegaly', 'volume': '56', 'author': 'Cats A.', 'year': '1996', 'journal-title': 'Cancer Research'} / Cancer Research / Increased epithelial cell proliferation in the colon of patients with acromegaly by Cats A. (1996)
  9. 10.1126/science.279.5350.563
  10. 10.1002/jcp.1041580110
  11. 10.1210/jcem-73-4-727
  12. 10.1056/NEJM197911223012102
  13. 10.1210/jc.76.4.1031
  14. {'key': 'e_1_2_6_15_1', 'first-page': '1974', 'article-title': 'Expression of p53 and 17p allelic loss in colorectal carcinoma', 'volume': '52', 'author': 'Cunningham J.', 'year': '1992', 'journal-title': 'Cancer Research'} / Cancer Research / Expression of p53 and 17p allelic loss in colorectal carcinoma by Cunningham J. (1992)
  15. 10.1210/jc.80.11.3223
  16. {'key': 'e_1_2_6_17_1', 'first-page': '164', 'article-title': 'Immunoreactive IGF‐II in serum of healthy subjects and patients with growth hormone disturbances and uraemia', 'volume': '107', 'author': 'Enberg G.', 'year': '1984', 'journal-title': 'Acta Endocrinologica'} / Acta Endocrinologica / Immunoreactive IGF‐II in serum of healthy subjects and patients with growth hormone disturbances and uraemia by Enberg G. (1984)
  17. 10.1210/jcem-72-2-245
  18. 10.1210/jc.82.7.2308
  19. 10.1016/s0140-6736(97)10384-1
  20. 10.1046/j.1365-2265.1997.1100922.x
  21. 10.1016/0003-2697(86)90507-5
  22. 10.1177/29.4.6166661 / Journal of Histochemistry and Cytochemistry / Use of avidin‐biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures by Hsu S.M. (1981)
  23. {'key': 'e_1_2_6_24_1', 'first-page': '27', 'article-title': 'Acromegaly and colon cancer', 'volume': '97', 'author': 'Ituarte E.M.', 'year': '1984', 'journal-title': 'Annals of Internal Medicine'} / Annals of Internal Medicine / Acromegaly and colon cancer by Ituarte E.M. (1984)
  24. 10.1038/bjc.1994.164
  25. 10.1210/endo.138.4.5177 / Endocrinology / Nuclear localization of insulin‐like growth factor binding protein‐3 in a lung cancer cell line by Jaques G. (1997)
  26. 10.1046/j.1365-2265.1997.1911029.x
  27. 10.1210/er.16.1.3
  28. 10.1016/0026-0495(94)90199-6
  29. 10.1111/j.1365-2265.1994.tb03788.x
  30. 10.1038/bjc.1996.206
  31. 10.1210/jc.77.1.229
  32. 10.1210/jc.82.12.3944
  33. 10.1111/j.1365-2265.1994.tb01824.x
  34. 10.1093/jnci/91.7.620
  35. 10.1038/bjc.1997.337
  36. 10.1016/S1096-6374(98)80300-6
  37. {'key': 'e_1_2_6_38_1', 'first-page': '201', 'article-title': 'A monoclonal antibody to human insulin‐like growth factor‐I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor', 'volume': '2', 'author': 'Morrell D.J.', 'year': '1989', 'journal-title': 'Journal of Clinical Endocrinology and Metabolism'} / Journal of Clinical Endocrinology and Metabolism / A monoclonal antibody to human insulin‐like growth factor‐I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor by Morrell D.J. (1989)
  38. {'key': 'e_1_2_6_39_1', 'first-page': '4680', 'article-title': 'Role of membrane and secreted insulin‐like growth factor binding protein‐2 in the regulation of insulin‐like growth factor action in lung tumors', 'volume': '53', 'author': 'Reeve J.G.', 'year': '1993', 'journal-title': 'Cancer Research'} / Cancer Research / Role of membrane and secreted insulin‐like growth factor binding protein‐2 in the regulation of insulin‐like growth factor action in lung tumors by Reeve J.G. (1993)
  39. 10.1038/bjc.1990.163
  40. 10.1002/1097-0142(19911015)68:8<1673::AID-CNCR2820680802>3.0.CO;2-0
  41. 10.1111/j.1365-2265.1991.tb03495.x
  42. 10.1507/endocrj.43.Suppl_S71
  43. 10.1210/endo.137.5.8612513 / Endocrinology / Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin‐like growth factor (IGF) IGF‐II and IGF binding protein‐4: Role of IGF‐II by Singh P. (1996)
  44. 10.1001/archinte.154.11.1272
  45. 10.1210/jc.85.1.183
  46. 10.1530/eje.0.1310235
  47. 10.1093/jnci/90.12.911
  48. 10.1172/JCI114797
  49. 10.1172/JCI110379
Dates
Type When
Created 22 years, 5 months ago (March 11, 2003, 5:48 a.m.)
Deposited 1 year, 10 months ago (Oct. 16, 2023, 9:15 p.m.)
Indexed 1 month ago (July 30, 2025, 10:43 a.m.)
Issued 24 years, 5 months ago (April 1, 2001)
Published 24 years, 5 months ago (April 1, 2001)
Published Online 23 years, 7 months ago (Jan. 12, 2002)
Published Print 24 years, 5 months ago (April 1, 2001)
Funders 0

None

@article{Miraki_Moud_2001, title={Increased levels of insulin‐like growth factor binding protein‐2 in sera and tumours from patients with colonic neoplasia with and without acromegaly}, volume={54}, ISSN={1365-2265}, url={http://dx.doi.org/10.1046/j.1365-2265.2001.01221.x}, DOI={10.1046/j.1365-2265.2001.01221.x}, number={4}, journal={Clinical Endocrinology}, publisher={Wiley}, author={Miraki‐Moud, F. and Jenkins, P. J. and Fairclough, P. D. and Jordan, S. and Bustin, S. A. and Jones, A. M. and Lowe, D. G. and Monson, J. P. and Grossman, A. B. and Besser, G. M. and Camacho‐Hübner, C.}, year={2001}, month=apr, pages={499–508} }